T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.76B |
| 2 |
Eli Lilly
LLY
|
+$1.4B |
| 3 |
Bank of America
BAC
|
+$1.3B |
| 4 |
Tesla
TSLA
|
+$1.19B |
| 5 |
Wells Fargo
WFC
|
+$784M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$6.47B |
| 2 |
Amazon
AMZN
|
+$3.71B |
| 3 |
Yum! Brands
YUM
|
+$2.84B |
| 4 |
Salesforce
CRM
|
+$2.77B |
| 5 |
Fortive
FTV
|
+$2.41B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 18.72% |
| 3 | Consumer Discretionary | 14.62% |
| 4 | Financials | 10.36% |
| 5 | Communication Services | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
1stdibs.com
DIBS
$163M
| $597K | ﹤0.01% |
94,865
-30,109
| -24% | -$195K |
|
|
FARO
2027
DELISTED
Faro Technologies
FARO
| $597K | ﹤0.01% |
21,735
-3,409
| -14% | -$111K |
|
2028
SmartRent
SMRT
$278M
| $597K | ﹤0.01% |
262,558
+251,205
| +2,213% | +$991K |
|
|
GTHX
2029
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $597K | ﹤0.01% |
47,765
| – | – |
|
|
AAT
2030
American Assets Trust
AAT
$1.39B
| $595K | ﹤0.01% |
23,104
+9,363
| +68% | +$268K |
|
2031
Outset Medical
OM
$84.6M
| $595K | ﹤0.01% |
2,488
-187,449
| -99% | -$50.2M |
|
2032
RadNet
RDNT
$6.06B
| $595K | ﹤0.01% |
29,213
+3,721
| +15% | +$75K |
|
|
BRG
2033
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $595K | ﹤0.01% |
22,259
-477
| -2% | -$12.6K |
|
2034
Transmedics
TMDX
$3.02B
| $594K | ﹤0.01% |
14,224
+5,803
| +69% | +$252K |
|
2035
Emergent Biosolutions
EBS
$233M
| $592K | ﹤0.01% |
28,139
-104,788
| -79% | -$2.92M |
|
|
SPTN
2036
DELISTED
SpartanNash
SPTN
| $592K | ﹤0.01% |
20,399
-3,389
| -14% | -$105K |
|
2037
Shore Bancshares
SHBI
$801M
| $590K | ﹤0.01% |
34,027
+16,480
| +94% | +$313K |
|
2038
Uranium Energy
UEC
$5.54B
| $588K | ﹤0.01% |
167,923
+47,012
| +39% | +$180K |
|
2039
LivePerson
LPSN
$35.9M
| $587K | ﹤0.01% |
4,151
+1,264
| +44% | +$242K |
|
|
BDN
2040
Brandywine Realty Trust
BDN
$541M
| $585K | ﹤0.01% |
86,644
+11,116
| +15% | +$94.9K |
|
2041
International Seaways
INSW
$4.58B
| $582K | ﹤0.01% |
16,565
-1,451,135
| -99% | -$40.2M |
|
2042
FuelCell Energy
FCEL
$1.63B
| $581K | ﹤0.01% |
5,676
+12
| +0.2% | +$1.44K |
|
2043
Fastly Inc
FSLY
$4.78B
| $581K | ﹤0.01% |
63,375
+8,052
| +15% | +$85.7K |
|
2044
Vicor
VICR
$10.4B
| $581K | ﹤0.01% |
9,809
+1,457
| +17% | +$96.2K |
|
|
PGRE
2045
DELISTED
Paramount Group
PGRE
| $577K | ﹤0.01% |
92,543
+16,373
| +21% | +$118K |
|
|
KRON
2046
DELISTED
Kronos Bio
KRON
| $575K | ﹤0.01% |
171,186
-228,125
| -57% | -$1.03M |
|
2047
Live Oak Bancshares
LOB
$1.98B
| $574K | ﹤0.01% |
18,748
-5,621,359
| -100% | -$202M |
|
2048
PJT Partners
PJT
$4.36B
| $574K | ﹤0.01% |
8,582
+1,492
| +21% | +$105K |
|
2049
Alight
ALIT
$377M
| $573K | ﹤0.01% |
3,905
+1,140
| +41% | +$176K |
|
|
ECHO
2050
EchoStar
ECHO
$26.6B
| $573K | ﹤0.01% |
34,764
+4,766
| +16% | +$89.1K |
|
Similar funds
T. Rowe Price Associates's Q3 2022 Portfolio in Review
As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.
- T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
- T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
- T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
- T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
- T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
- T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.
Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.